During the past decade, Vista Oncology Inc PS conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vista Oncology Inc PS" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Oncotherapeutics" with 2 trials sponsored, "Seagen Inc." with 2 trials sponsored and "ADC Therapeutics S.A." with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vista Oncology Inc PS" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Vista Oncology Inc PS" are "Multiple Myeloma" (3 trials), "Follicular Lymphoma" (2 trials), "Pancreatic Cancer" (2 trials), "Diffuse Large B Cell Lymphoma" (1 trials) and "Diffuse Large B-Cell Lymphoma Refractory" (1 trials). Many other conditions were trialed in "Vista Oncology Inc PS" in a lesser frequency.

Most popular intervention types in "Vista Oncology Inc PS" are "Drug" (17 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (3 trials), "Dexamethasone" (2 trials), "PLD" (2 trials), "doxorubicin" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vista Oncology Inc PS" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Vista Oncology Inc PS". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Vista Oncology Inc PS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vista Oncology Inc PS, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".